Astrazeneca Pharma India dividend 2025

ASTRAZEN

9331

109.00 (1.18%)
Last updated on 3 Oct, 2025 | 15:31 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Astrazeneca Pharma India Dividend Details

Record Date

18-Jul-2025

Ex Date

18-Jul-2025

Dividend Type

Equity Share

Dividend Per Share

1600.00

Astrazeneca Pharma India Dividend History

Record DateDividend Per ShareDividend TypeEx-Date
18-Jul-202516.00Equity Share18-Jul-2025

Upcoming Dividends by Indian Companies

View More
CompanyDividends RatioAnnouncementRecord DateDividends Date
LTIMindtree Ltd.001-Oct-202524-Oct-202524-Oct-2025
ICICI Lombard General Insurance Company Ltd.025-Sep-202523-Oct-202523-Oct-2025
Tata Consultancy Services Ltd.022-Sep-202515-Oct-202515-Oct-2025
Rashtriya Chemicals and Fertilizers Ltd.0.13227-May-202510-Oct-202510-Oct-2025
Hexaware Technologies Ltd.5.7501-Oct-202510-Oct-202510-Oct-2025
CyberTech Systems And Software Ltd.229-Sep-202506-Oct-202506-Oct-2025

Astrazeneca Pharma India Dividend FAQs

The latest dividend declared by Astrazeneca Pharma India is of 16 per share for the financial year as announced on 18-Jul-2025.

Registered shareholders who own Astrazeneca Pharma India’s shares on or before the record date of 18-Jul-2025 set by the company are eligible to receive the dividend. You will not be entitled to the payout if you purchase shares on or after the ex-dividend date of 18-Jul-2025.

You can expect to receive Astrazeneca Pharma India’s dividend in your bank account linked to your Demat account within 25 to 45 business days after the record date of 18-Jul-2025. The record date is when Astrazeneca Pharma India identifies eligible shareholders for the dividend payment.

The annual dividend paid by Astrazeneca Pharma India varies according to its financial performance and dividend policy. Generally, companies in different sectors exhibit varying dividend yields. To determine Astrazeneca Pharma India's specific annual dividend, it’s advisable to consult the company's official investor relations website or recent financial statements.